ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 87 filers reported holding ALLOVIR INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,022,979 | -41.6% | 475,804 | -7.6% | 0.00% | – |
| Q2 2023 | $1,751,534 | -0.1% | 515,157 | +15.7% | 0.00% | – |
| Q1 2023 | $1,754,132 | -25.6% | 445,211 | -3.2% | 0.00% | – |
| Q4 2022 | $2,358,948 | -34.3% | 459,834 | +1.1% | 0.00% | -100.0% |
| Q3 2022 | $3,590,000 | +229.4% | 455,025 | +62.8% | 0.00% | – |
| Q2 2022 | $1,090,000 | -43.2% | 279,551 | -1.7% | 0.00% | – |
| Q1 2022 | $1,920,000 | -50.2% | 284,503 | -4.6% | 0.00% | -100.0% |
| Q4 2021 | $3,857,000 | -47.9% | 298,078 | +0.9% | 0.00% | 0.0% |
| Q3 2021 | $7,400,000 | +29.3% | 295,298 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $5,722,000 | -16.1% | 289,879 | -0.6% | 0.00% | 0.0% |
| Q1 2021 | $6,823,000 | -16.7% | 291,586 | +36.8% | 0.00% | -50.0% |
| Q4 2020 | $8,193,000 | +39.4% | 213,157 | -0.3% | 0.00% | +100.0% |
| Q3 2020 | $5,877,000 | – | 213,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $28,611 | 1.60% |
| GMT CAPITAL CORP | 2,758,846 | $14,152,880 | 0.65% |
| SVB FINANCIAL GROUP | 43,019 | $220,687 | 0.60% |
| Regency Capital Management Inc.\DE | 75,025 | $384,878 | 0.44% |
| Redmile Group, LLC | 1,907,969 | $9,787,881 | 0.40% |
| Samsara BioCapital, LLC | 82,336 | $422,384 | 0.09% |
| Alkeon Capital Management | 4,605,104 | $23,624,184 | 0.09% |
| Woodline Partners LP | 1,087,090 | $5,576,772 | 0.08% |
| XTX Topco Ltd | 53,422 | $274,055 | 0.06% |
| Virtus ETF Advisers LLC | 20,906 | $107,248 | 0.06% |